Day: February 24, 2026

Beam Therapeutics Reports Fourth Quarter and Year-End 2025 Financial Results and Announces New Liver-Targeted Genetic Disease Program in Phenylketonuria (PKU)

Written by Customer Service on February 24, 2026. Posted in Earnings Releases And Operating Results.

New Program Designed as Platform-based Approach for Direct Correction of Mutations Causing PKU; Investigational New Drug (IND) Filing for BEAM‑304 Anticipated in 2026 Updated Phase 1/2 Data and Next Steps for Pivotal Development for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) on Track for Q1 2026 Strategic Financing Agreement with Sixth Street Provides up to $500 Million in Long-term, Non-dilutive Capital to Fund Anticipated Launch of Risto-cel in Sickle Cell Disease (SCD); U.S. Biologics License Application (BLA) Submission Expected as Early as Year-End 2026 Expected Cash Runway Now into Mid-2029 Through Execution of Key Clinical, Regulatory and Commercial Milestones Beam to Host Investor Webcast Today, February 24, 2026, at 8:00 a.m. ET CAMBRIDGE, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) — Beam Therapeutics Inc. (Nasdaq:...

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2025

Written by Customer Service on February 24, 2026. Posted in Earnings Releases And Operating Results.

― Announced positive 12-week results from the 20 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD) ― ― 20 mg cohort demonstrated rapid and robust fetal hemoglobin (HbF) induction, with mean absolute HbF increasing by 12.2% from a baseline of 7.1% to 19.3% at Week 12, improvements in markers of hemolysis and anemia, and encouraging trends in vaso-occlusive crisis (VOC) reduction ― ― Fulcrum plans to initiate a potential registration-enabling trial in the second half of 2026 ― ― Ended 2025 with $352.3 million in cash, cash equivalents, and marketable securities; cash runway into 2029 ― CAMBRIDGE, Mass., Feb. 24, 2026 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (Fulcrum) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients...

OR Royalties Announces Acquisition of Additional Royalties on Spring Valley in Nevada

Written by Customer Service on February 24, 2026. Posted in Public Companies.

MONTRÉAL, Feb. 24, 2026 (GLOBE NEWSWIRE) — OR Royalties Inc. (“OR Royalties” or the “Company”) (OR: TSX & NYSE) is pleased to announce that it has entered into a definitive agreement to acquire Terraco Gold Corp. (“Terraco”), a wholly-owned subsidiary of Sailfish Royalty Corp., which indirectly owns net smelter return (“NSR”) royalty assets (the “NSR Royalties”), largely consisting of royalties that cover Solidus Resources LLC’s (“Solidus”) Spring Valley Gold Project (“Spring Valley” or the “Project”) located in Pershing County, Nevada, USA. OR Royalties is acquiring Terraco and the NSR Royalties for total cash consideration of $168 million (the “Transaction”). The Transaction is subject to the approval of the TSX Venture Exchange and other customary closing conditions, and is expected to be completed in the first half of...

Amendment of the Liquidity Agreement with Kepler Cheuvreux

Written by Customer Service on February 24, 2026. Posted in Public Companies.

PRESS RELEASE Bloomberg (THEON:NA) / Reuters (THEON.AS)24 February 2026 – Theon International Plc (THEON) (ISIN: CY0200751713) entered on 21st January 2026, into a Liquidity Contract with Kepler Cheuvreux (the “Liquidity Agreement”). Under the Liquidity Agreement, an initial amount of €1 million and 33,000 Shares were made available to Kepler Cheuvreux, to enhance the liquidity of the Shares in THEON on the regulated market of Euronext Amsterdam. On February 18, 2026, Parties have agreed that THEON will make available an additional amount of €2 million to Kepler Chevreux in relation to the implementation of the Liquidity Agreement. The other key terms of the Liquidity Agreement remain unchanged as per the earlier announcement dated 27 January 2026:the Liquidity Agreement was implemented from 26 January 2026 onwards for...

Goliath Reports Numerous High-Grade Intercepts Including 24.16 g/t AuEq Over 7.00 Meters, Grade Values Increased By 19.6 % In 56 Gold Equivalent Drill Results, And Expands Vast Stacked Vein System At Surebet Discovery, Golden Triangle, B.C.

Written by Customer Service on February 24, 2026. Posted in Public Companies.

Infographic 1Infographic 1Infographic 2Infographic 2Infographic 3Infographic 3Infographic 4Infographic 4Infographic 5Infographic 5Infographic 6Infographic 6Infographic 7Infographic 7Infographic 8Infographic 8Infographic 9Infographic 9Infographic 10Infographic 10Infographic 11Infographic 11Infographic 12Infographic 12Infographic 13Infographic 13Infographic 14Infographic 14Infographic 15Infographic 15Accounting for Silver, Copper, Lead and Zinc within these 56 drill hole results, Goliath reports an average 19.6 % increase in overall grade values from these previously announced Gold only assays, with numerous high-grade intercepts including 24.16 g/t AuEq over 7.00 meters. Across all 110 drill holes completed...

Pelican Acquisition Corporation and Greenland Energy Announce SEC Effectiveness of Registration Statement

Written by Customer Service on February 24, 2026. Posted in Public Companies.

Extraordinary General Meeting of Shareholders to Approve Business Combination Scheduled for March 17, 2026 HOUSTON, Feb. 24, 2026 (GLOBE NEWSWIRE) — Pelican Acquisition Corporation (NASDAQ: PELI) (“Pelican”), a publicly traded special purpose acquisition company, today announced that the U.S. Securities and Exchange Commission (“SEC”) has declared effective its registration statement on Form S-4 (the “Registration Statement”) in connection with its proposed business combination with Greenland Exploration Limited (“Greenland Exploration”) and March GL Company (“March GL”). The combined company will operate as Greenland Energy Company (“Greenland”) and is expected to list on Nasdaq under the ticker symbol “GLND” upon closing. The Registration Statement includes a proxy statement/prospectus for Pelican’s shareholders in connection...

Form 8.3 – [IDOX PLC – 23 02 2026] – (CGWL)

Written by Customer Service on February 24, 2026. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree IDOX PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: IDOX PLC AS AN ASSOCIATE OF THE CANACCORD...

Cautious Holiday Spending Appears to Have Softened the Typical January Credit Card Delinquency Spike

Written by Customer Service on February 24, 2026. Posted in Public Companies.

Equifax Canada reports that financial stress grew in Q4, but at a slower rate than prior years Equifax Canada® Market Pulse Quarterly Consumer Credit Trends and Insights TORONTO, Feb. 24, 2026 (GLOBE NEWSWIRE) — Equifax® Canada’s Q4 2025 Market Pulse Consumer Credit Trends and Insights data suggests a clear divergence in financial health across the country. As 2025 came to a close, the pressures of a cooling labour market and persistent inflation led to a continued widening split in financial health: older consumers with higher credit scores showed resilience; while younger consumers and those in Ontario & Western provinces showed signs of financial weakening. Total consumer debt climbed to $2.65 trillion in Q4 2025, a 3.13 per cent increase year-over-year, driven by a $50.26 billion rise in mortgage balances and a 4.50 per...

Festi hf.: Annual General Meeting March 5, 2026 – final agenda, proposals and candidates for the Board of Directors.

Written by Customer Service on February 24, 2026. Posted in Public Companies.

The Annual General Meeting of Festi hf. will be held on Thursday, March 5, 2026, at 10:00 a.m. at the Company’s headquarters at Dalvegur 10 – 14, Kópavogur. No changes have been made to the agenda and proposals that were published with the meeting notice on February 10, 2026. No further proposals were received from shareholders regarding the appointment of committee members to the Company’s Nomination Committee. The deadline for submitting candidacies for the Board of Directors has expired. The following persons have submitted candidacies for the Board of Directors:Edda Blumenstein Guðjón Auðunsson Guðjón Reynisson Hjörleifur Pálsson Sigurlína IngvarsdóttirAccording to the Company’s Articles of Association, the Board of Directors shall be composed of five members elected at the Annual General Meeting for a term of one year...

Amoéba: final phase for marketing authorisation of AXPERA

Written by Customer Service on February 24, 2026. Posted in Earnings Releases And Operating Results.

Chassieu, Feb. 24, 2026 (GLOBE NEWSWIRE) —The ANSES evaluation process for the application submitted in March 2025 is currently in its final stage. At the same time, French and Italian agricultural sectors have begun procedures to obtain derogatory marketing authorisations for the use of AXPERA to combat fungal diseases from the start of their production season. At this stage, there is nothing to prevent the marketing authorisation of the product in 2026.Chassieu (France), 23 February 2026 – 6:00 pm – Amoéba (FR0011051598 – ALMIB), industrial greentech specialised in the development of natural microbiological solutions based on the patented use of amoebae, announces that the ANSES (French Agency for Food, Environmental and Occupational Health & Safety) has initiated the final phase of its assessment of the...

Day: February 24, 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals